Your account is not claimed yet. You can sign up with ORCID to claim your account.

Salvador Macip

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 13

Top Venues

Cell death discovery

Nanoscale advances

British journal of haematology

Cancers

University of Leicester

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Leicester Jan 8o 2008

United Kingdom

Associate Professor :: Molecular and Cell Biology

Publications

Elena Piletska, Dana Thompson, Rebecca Jones, Alvaro Garcia Cruz, Marta Poblocka, Francesco Canfarotta, Rachel Norman, Salvador Macip, Donald J L Jones, Sergey Piletsky
Snapshot imprinting as a tool for surface mapping and identification of novel biomarkers of senescent cells. Nanoscale advances 4 (24) (2022)
Elena Piletska, Kirabo Magumba, Lesslly Joseph, Alvaro Garcia Cruz, Rachel Norman, Rajinder Singh, Antonella F S Tabasso, Donald J L Jones, Salvador Macip, Sergey Piletsky
Molecular imprinting as a tool for determining molecular markers: a lung cancer case. RSC advances 12 (28) (2022)
Vinesh Dhokia, John A Y Moss, Salvador Macip, Joanna L Fox
At the Crossroads of Life and Death: The Proteins That Influence Cell Fate Decisions. Cancers 14 (11) (2022)
Elena Piletska, Dana Thompson, Rebecca Jones, Alvaro Garcia Cruz, Marta Poblocka, Francesco Canfarotta, Rachel Norman, Salvador Macip, Donald J L Jones, Sergey Piletsky
Snapshot imprinting as a tool for surface mapping and identification of novel biomarkers of senescent cells. Nanoscale advances 4 (24) (2022)
Vinesh Dhokia, Salvador Macip
A master of all trades - linking retinoids to different signalling pathways through the multi-purpose receptor STRA6. Cell death discovery 7 (1) (2021)
Marta Falcicchio, Jake A Ward, Salvador Macip, Richard G Doveston
Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer. Cell death discovery 6 (1) (2020)
Konstantinos Polymeros, David S Guttery, Roger Hew, Rachael Bishop, Elizabeth Stannard, Salvador Macip, Paul Symonds, Esther L Moss
Differences in the molecular profile of endometrial cancers from British White and British South Asian women. PloS one 15 (6) (2020)
Akang E Ekpenyong-Akiba, Marta Poblocka, Mohammad Althubiti, Miran Rada, Diana Jurk, Sandra Germano, Gabriella Kocsis-Fodor, Yu Shi, Juan J Canales, Salvador Macip
Amelioration of age-related brain function decline by Bruton's tyrosine kinase inhibition. Aging cell 19 (1) (2019)
Yixiang Chen, Chloé Peubez, Sandrine Jayne, Gabriella Kocsis-Fodor, Martin J S Dyer, Salvador Macip
Differential activation of pro-survival pathways in response to CD40LG/IL4 stimulation in chronic lymphocytic leukaemia cells. British journal of haematology 184 (5) (2018)
Yixiang Chen, Chloé Peubez, Victoria Smith, Shiqiu Xiong, Gabriella Kocsis-Fodor, Ben Kennedy, Simon Wagner, Constantine Balotis, Sandrine Jayne, Martin J S Dyer, Salvador Macip
CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL. Journal of cellular and molecular medicine 23 (1) (2018)
Miran Rada, Nickolai Barlev, Salvador Macip
BTK modulates p73 activity to induce apoptosis independently of p53. Cell death discovery 4 (2018)
Harriet Sarah Walter, Sandrine Jayne, Simon A Rule, Guillaume Cartron, Judith Trotman, Salvador Macip, Lionel Karlin, Ceri Jones, Charles Herbaux, Philippe Quittet, Nimish Shah, Claire V Hutchinson, Christopher Fegan, Yingsi Yang, Siddhartha Mitra, Gilles Andre Salles, Martin J S Dyer
Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059. Blood 129 (20) (2017)
Yixiang Chen, Sandra Germano, Ghalia Shelmani, Diana Kluczna, Sandrine Jayne, Martin J S Dyer, Salvador Macip
Paradoxical activation of alternative pro-survival pathways determines resistance to MEK inhibitors in chronic lymphocytic leukaemia. British journal of haematology 182 (6) (2017)

Salvador Macip.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Salvador Macip